Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,777,930
-
Share change
-
-145,068
-
Total reported value
-
$810,748
-
Price per share
-
$0.21
-
Number of holders
-
15
-
Value change
-
-$465,616
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of ENSYSCE BIOSCIENCES INC - COM (ENSC) as of Q3 2022
As of 30 Sep 2022,
ENSYSCE BIOSCIENCES INC - COM (ENSC) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,777,930 shares.
The largest 10 holders included
HG Vora Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., STIFEL FINANCIAL CORP, Cerity Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, NORTHERN TRUST CORP, Virtu Financial LLC, and STATE STREET CORP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.